Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BR.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BR.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CP.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CP.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CP.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.39EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.40EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BM.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used